Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 3,846 | 3,997 | 3,860 | 3,857 | 3,605 |
Cost of Goods | 1,627 | 1,593 | 1,568 | 1,614 | 1,546 |
Gross Profit | 2,219 | 2,403 | 2,292 | 2,243 | 2,059 |
Operating Expenses | 2,844 | 2,726 | 2,618 | 2,714 | 2,541 |
Operating Income | 2 | 271 | 242 | 142 | 65 |
Other Income | 18 | 13 | 5 | 5 | 16 |
Pre-tax Income | 20 | 284 | 247 | 147 | 80 |
Net Income Continuous | 20 | 270 | 247 | 147 | 80 |
Net Income | $20 | $270 | $247 | $147 | $80 |
EPS Basic Total Ops | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
EPS Basic Continuous Ops | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
EPS Diluted Total Ops | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
EPS Diluted Continuous Ops | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
EBITDA(a) | $299 | $586 | $569 | $440 | $381 |